Yungjin Pharm (003520.KS) Earnings Analysis

Yungjin Pharm (003520.KS) has no confirmed upcoming earnings date. Trailing P/E -65.30.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 003520.KS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 003520.KS. This page updates as the calendar is published.

003520.KS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-01-15-2.05 KRWn/an/an/a
2025-08-042 KRWn/an/an/a
2025-05-155.34 KRWn/an/an/a
2025-03-04-5.28797 KRWn/an/an/a
2024-10-31-2.3894 KRWn/an/an/a
2024-08-01-7.96209 KRWn/an/an/a

003520.KS valuation and analyst view

Trailing P/E-65.30
Trailing EPS-19.06017 KRW
Price / book2.49
Dividend yield0.00%
Market cap216.54B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Yungjin Pharm (003520.KS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 003520.KS. This page updates as the calendar is published.

Did 003520.KS beat earnings last quarter?

Consensus estimate data was not available for 003520.KS's 2026-01-15 report.

What is 003520.KS's current P/E ratio and EPS?

003520.KS trades at a trailing P/E of -65.30 on trailing EPS of -19.06017355597839 KRW.

What do analysts rate 003520.KS?

003520.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.